Swift Biosciences Expands Coronavirus Research With ACE2 Swift Normalase Amplicon Panel

(ANN ARBOR, MICH.  August 17, 2020) Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to providing... Read more

PerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection

Enables Labs to Quickly Ramp up Testing Capacity and Generate Results Faster WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 17, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a series of explorer™ workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day.... Read more

New, Easy-to-Use, Compact, Ion Chromatography System Simplifies Water Analysis

Thermo Scientific Dionex Easion Ion Chromatography System makes everyday ion analysis simpler, while reducing total cost of ownership and need for maintenance SUNNYVALE, Calif., Aug. 17, 2020 /PRNewswire/ — Small environmental and academic teaching laboratories specializing in water analysis can benefit from simpler setup and operation and improved quality with a new, compact ion chromatography (IC)... Read more

Bio-Techne Announces Release of a New SARS-CoV-1/2 Spike RBD Llamabody Recombinant Antibody That Blocks Viral Entry

MINNEAPOLIS, Aug. 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds to the SARS-CoV-2 spike receptor binding domain (RBD) and blocks the virus from binding to its host receptor, ACE-2, inhibiting viral infection . The SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody is the... Read more

Promega Launches COVID-19 Serology Test: Lumit™ Dx SARS-CoV-2 Immunoassay Workflow is Quick, Simple and Scalable for High-Throughput Antibody Detection

Madison, WI USA. (August 11, 2020) Promega Corporation today announced the launch of its new serological antibody test for COVID-19 to detect the presence of antibodies against the SARS-CoV-2 virus. A positive result may indicate whether an individual has been exposed to, and mounted an immune response to, the virus. Promega has submitted an application to the US... Read more

New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution

New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution Zero-loss energy filters enable life scientists to view protein structures in unprecedented detail HILLSBORO, Ore., Aug. 10, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific... Read more

Brain Gain: Stunning new MRI tech advances neuro research and clinical translation capabilities at #ISMRM20

Waukesha, WI – August 10, 2020 – At this year’s virtual ISMRM meeting, GE Healthcare is showcasing new technologies to enable neuro research to better understand Alzheimer’s disease and traumatic brain injury, as well as accelerate clinical translation. The 510(k)-pending SIGNA 7.0T [1], as well as research devices SIGNA ultra-high performance (UHP) 3.0T and the... Read more

Pacific Biosciences Announces New Chief Executive Officer

Christian O. Henry Named Chief Executive OfficerJohn F. Milligan, Ph.D. Named Chairman of the BoardBen Gong Named Interim CFOMENLO PARK, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Christian O. Henry as President... Read more

Thermo Fisher Scientific's COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution

Thermo Fisher Scientific’s COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution WALTHAM, Mass., Aug. 5, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing... Read more

Thermo Fisher Scientific's COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution

WALTHAM, Mass., Aug. 5, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing global demand for COVID-19 testing. The high-throughput system enables laboratories to double or even... Read more